The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Dietary Supplementation with Lactobacilli and Bifidobacteria Is Well Tolerated and Not Associated with Adverse Events during Late Pregnancy and Early Infancy
Open accessAbstract
Lactic acid bacteria and bifidobacteria are increasingly being administered to pregnant women and infants with the intention of improving health. Although these organisms have a long record of safe use, it is important to identify any adverse effects in potentially vulnerable populations. In a randomized, double-blinded, placebo-controlled trial, we evaluated the safety of a bacterial dietary supplement for the prevention of atopy in infants. Two strains of lactobacilli (Lactobacillus salivarius CUL61 and Lactobacillus paracasei CUL08) and bifidobacteria (Bifidobacterium animalis subsp. lactis CUL34 and Bifidobacterium bifidum CUL20) with a total of 1 x 10(10) colony-forming units were administered daily to women during the last month of pregnancy and to infants aged 0-6 mo. Adverse events (AE) were classified according to WHO International Statistical Classification of Diseases criteria. Common symptoms were recorded by regular questionnaires. Baseline characteristics of 220 mother-infant dyads in the treatment and 234 in the placebo group were similar. Compliance with the trial interventions, loss to follow-up, symptoms, drug usage, infant growth, method of feeding, visits to the doctor, and mothers' assessment of infant health were similar in the 2 groups. Fifteen (6.8%) mothers and 73 (33.2%) infants in the treatment group and 21 (9.0%) mothers and 75 (32.1%) infants in the placebo group reported AE (P = 0.49 and P = 0.84, respectively). Severe AE occurred in 18 mothers and 63 infants with a similar frequency in each group. None of the AE were attributed to the intervention. Our findings support the safe use of this consortium of organisms during pregnancy and early infancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In such vulnerable patient groups, intestinal barrier dysfunction increases the risk of adverse effects from probiotics [81] and may contribute to infection development, which can subsequently lead to sepsis or inflammation [19].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [81]
Citations
Cites
International Statistical Classification of Diseases and Related Health Problems
(2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,182
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776
Taylor, A. L., Dunstan, J. A., & Prescott, S. L. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.036 · Cited by 541
Snydman, D. R. (2008) · Clinical Infectious Diseases · doi:10.1086/523331 · Cited by 336
Kukkonen, A. K., Savilahti, E., Haahtela, T., Juntunen‐Backman, K., Korpela, R., Poussa, T. A., Tuure, T., & Kuitunen, M. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1192 · Cited by 220
Chouraqui, J. P. J., Grathwohl, D., Labaune, J. M., Hascoët, J., Montgolfier, I. D., LeClaire, M. M., Giarre, M., & Steenhout, P. G. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1365 · Cited by 144
Puccio, G., Cajozzo, C., Meli, F., Rochat, F., Grathwohl, D., & Steenhout, P. G. (2006) · Nutrition · doi:10.1016/j.nut.2006.09.007 · Cited by 128
Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects
Saavedra, J. M. (2007) · Nutrition in Clinical Practice · doi:10.1177/0115426507022003351 · Cited by 125
Dugoua, J.-J., Machado, M., Zhu, X., Chen, X., Koren, G., & Einarson, T. R. (2009) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34218-9 · Cited by 119
Cited by
Sorted by citations
Items 101–121 of 121
Plants and herbs for therapy of diabetes
Pramono, L. A. (2015) · Medical Journal of Indonesia · doi:10.13181/mji.v24i2.1260 · Cited by 2
Otiti, M. I., June, M. J., K’Oloo, A., Chomba, M., Dodd, J., Kiu, R., Hall, L. J., Wang, D., Otieno, K., Kariuki, S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5929784/v1 · Cited by 2
Self-citationThe Microbiome as an Endocrine Organ
Masetti, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00118-3 · Cited by 1
Coates, N., John, D. A., Jordan, S. E., Storey, M., Thornton, C. A., Garaiová, I., Wang, D., Allen, S. J., Michael, D. R., Plummer, S., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13050984 · Cited by 1
Self-citationProbiotyki w zapobieganiu i leczeniu alergii
Łoś-Rycharska, E., & Czerwionka‐Szaflarska, M. (2012) · Pediatria Polska · doi:10.1016/j.pepo.2012.08.002 · Cited by 1
İlaç Tedavisi ve Beslenmede Pediatriye Özgü Yaklaşımlar
Armağan, B., Demirbaş, E., & Ihlamur, M. (2024) · İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi · doi:10.38079/igusabder.1373380 · Cited by 1
Inositols and other supplements in the management of PCOS
Unfer, V., Monastra, G., Tilotta, M., Forte, G., & Dinicola, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00014-6 · Cited by 2
Taipale, T. J. (2012) · UTUPub (University of Turku) · Cited by 1
Preparing the Body for Pregnancy
Derbyshire, E. J. (2011) · Wiley eBooks · doi:10.1002/9781444344790.ch2
Gąsiorowska, J., & Czerwionka‐Szaflarska, M. (2010) · Pediatria Polska · doi:10.1016/s0031-3939(10)70563-1
Microbial Products Maintain Female Homeostasis
Amdekar, S., Khare, M., Shrivastava, V. K., Kumar, A., & Singh, V. K. (2017) · Wiley eBooks · doi:10.1002/9781119048961.ch9
Food Suplements During Pregnancy Benefits and Risks: A Literature Review
Stoilova, L., Stoilov, B., & Staynova, R. A. (2019) · European Scientific Journal ESJ · doi:10.19044/esj.2019.v15n24p13
Vandenplas, Y., Huys, G. R. B., & Daube, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_45
Briley, A. L., & Tribe, R. M. (2018) · http://isrctn.com/ · doi:10.1186/isrctn11690200
Role of Probiotics in Diabetes Mellitus
Yadav, A. R. (2021) · Journal of Infectious Diseases & Travel Medicine · doi:10.23880/jidtm-16000154
Philippine guidelines on the dietary primary prevention of allergic diseases in children
Casis-Hao, R. J., Genuino, M. L. G., Tan‐Lim, C. S. C., Capulong, R. D., Castor, M. A. R., Francisco, P. D., Guinto, V. T., Nano, A. L. M., Padua-Zamora, A. P., Recto, M. S. T., et al. (2024) · Asia Pacific Allergy · doi:10.5415/apallergy.0000000000000158
Otiti, M. I., Kariuki, S., Wang, D., Hall, L. J., ter Kuile, F. O., & Allen, S. J. (2022) · Figshare · doi:10.6084/m9.figshare.19663716
Self-citationBeneficial Effect of Nutraceuticals on Diabetes Mellitus
Das, S., Bhattacharya, H., Debnath, B., & Das, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813369126010006
Otiti, M. I., June, M. J., K’Oloo, A., Chomba, M., Dodd, J., Luo, Y., Kiu, R., Hall, L., Wang, D., Otieno, K., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102834
Self-citationPeng, C., Lu, C., Li, X., Zhang, L., Zeng, Y., Wu, X., Wu, T., He, F., & Shen, X. P. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109409
Metadata
- Authors
- Allen, S. J., Jordan, S., Storey, M., Thornton, C. A., Gravenor, M., Garaiova, I., Plummer, S. F., Wang, D., & Morgan, G.
- Affiliations
- Swansea University (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Allen, Stephen J.
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 140
- Issue
- 3
- Pages
- 483-488
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W2014544748
- Cited by
- 119
- References
- 16
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 12 · 2023: 3 · 2022: 7 · 2021: 12 · 2020: 12 · 2019: 7 · 2018: 9 · 2017: 8 · 2016: 6 · 2015: 8 · 2014: 4 · 2013: 8 · 2012: 5
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Keywords
- probiotics, lactobacilli, Bifidobacterium, dietary supplementation, safety, adverse events, atopy prevention, pregnancy, infancy, Lactobacillus salivarius, Lactobacillus paracasei, Bifidobacterium animalis subsp. lactis, Bifidobacterium bifidum, mother-infant dyads
- MeSH terms
- Adult, Bifidobacterium, Double-Blind Method, Female, Humans, Hypersensitivity, Immediate, Infant, Infant, Newborn, Lactobacillus, Pregnancy, Pregnancy Trimester, Third, Dietary Supplements, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
